TREA

79392996 - BDC

Follow

Information

  • Trademark
  • 79392996
  • Serial Number
    79392996
  • Registration Number
    7741579
  • Filing Date
    December 19, 2023
    a year ago
  • Registration Date
    April 01, 2025
    13 days ago
  • Transaction Date
    April 01, 2025
    13 days ago
  • Status Date
    April 01, 2025
    13 days ago
  • Published for Opposition Date
    February 11, 2025
    2 months ago
  • Location Date
    March 31, 2025
    14 days ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    ANDREACCHI,SAMANTHA ALEXIS
  • Attorney Docket Number
    B17012002000
    Attorney Name
    Christina M. Licursi
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BDC
Case File Statements
  • GS0051: Pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for suppressing tumors; pharmaceutical products for the treatment of cancer; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of oncology; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of ophthalmology; pharmaceutical preparations for use in the treatment and prevention of disease in the field of neurology; anti-infective pharmaceutical preparations for use in preventing and treating infections; pharmaceutical products and preparations for the treatment of respiratory disease; pharmaceutical preparations for the treatment and prevention of cardiovascular disease; pharmaceutical preparations for the treatment and prevention of metabolic disease; pharmaceutical products and preparations for the treatment and prevention of viral infections; pharmaceutical preparations for use in medical diagnostics and imaging; pharmaceutical preparations for the treatment and prevention of renal disease; pharmaceutical preparations for the treatment and prevention of gastrointestinal disease; pharmaceutical preparations for the treatment and prevention of muscular skeletal disease
  • GS0421: Scientific and technological services and research and design relating thereto, namely, scientific research and new product design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; medical research services, namely, industrial analysis and research services in the field of medicine; research and development services in the field of pharmaceutical preparations; medical research services; pharmaceutical research services, namely, pharmaceutical testing and clinical trials; scientific research in the nature of conducting clinical trials for others; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; scientific research consulting, namely, providing information consultancy and advisory services relating to the aforesaid in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents
Case File Event Statements
  • 4/4/2024 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 4/12/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/1/2024 - 9 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/30/2024 - 8 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/30/2024 - 8 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/17/2024 - 8 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/18/2024 - 12 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/2/2024 - 9 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/3/2024 - 9 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/16/2024 - 3 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/16/2024 - 3 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/16/2024 - 3 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/23/2025 - 2 months ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/5/2025 - 2 months ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/11/2025 - 2 months ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/11/2025 - 2 months ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/26/2025 - 19 days ago
    22 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/21/2025 - 2 months ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/21/2025 - 2 months ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/21/2025 - 2 months ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/21/2025 - 2 months ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/26/2025 - 19 days ago
    25 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 3/26/2025 - 19 days ago
    24 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/1/2025 - 13 days ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/1/2025 - 13 days ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 3/26/2025 - 19 days ago
    23 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/26/2025 - 19 days ago
    21 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/26/2025 - 19 days ago
    26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA